Mice with targeted replacement of human APOE2, APOE3, and APOE4 (APOE-TR mice) have been widely used to study the role of APOE4 in Alzheimer’s disease. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.